NVision

Summary active Updated May 14, 2026

This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.

Location Ulm, Germany
Founded 2015
Latest Stage Series B
Total Raised $120M

Founders

Sella Brosh Co-Founder & CEO

About

NVision is a quantum healthcare company applying quantum sensing and quantum computing to medical imaging and drug discovery 12. The company’s POLARIS platform enhances MRI signal detection of sugar-based imaging agents by orders of magnitude, enabling real-time metabolism measurement on standard MRI systems 12. NVision is expanding from quantum sensing into quantum computing with its new PIQC photonic platform using organic-molecule-based qubits integrated onto photonic chips for drug design applications 1. The $55M Series B announced May 13, 2026 was anchored by Abbott as sole strategic diagnostic investor, with participation from CDP Venture Capital, Playground Global, Matterwave/b2ventures, and Entrée Capital, plus a $17M venture loan from the European Investment Bank; total funding now stands at $120M 123.

Funding History

Date Round Amount Lead Co-investors
2026-05-13 Series B $55M Abbott CDP Venture Capital, Playground Global, Matterwave/b2ventures, Entrée Capital, European Investment Bank 123

What Investors Say

No independently sourced investor quotes found at this time.

What Founders Say

No independently sourced founder quotes found at this time.

Sources


  1. The Quantum Insider, “NVision Secures $55 Million Series B to Advance Quantum Healthcare Platform,” May 13, 2026. Accessed May 2026. https://thequantuminsider.com/2026/05/13/nvision-quantum-sensing-quantum-computing-therapies/

  2. HPCwire, “NVision Raises $55M, Expands from Quantum MRI Sensing into Quantum Computing,” May 13, 2026. Accessed May 2026. https://www.hpcwire.com/off-the-wire/nvision-raises-55m-expands-from-quantum-mri-sensing-into-quantum-computing/

  3. BioWorld, “Nvision secures $55 million, with backing from Abbott,” May 13, 2026. Accessed May 2026. https://www.bioworld.com/articles/731059-nvision-secures-55-million-with-backing-from-abbott